Marburg, Germany

Artur Bauhofer




Average Co-Inventor Count = 5.0

ph-index = 1

Forward Citations = 13(Granted Patents)


Company Filing History:


Years Active: 2011

Loading Chart...
Loading Chart...
Loading Chart...
1 patent (USPTO):Explore Patents

Title: Artur Bauhofer: Innovator in Inflammatory Disease Treatment

Introduction

Artur Bauhofer is a notable inventor based in Marburg, Germany. He has made significant contributions to the field of medicine, particularly in the treatment of inflammatory diseases. His innovative approach combines various pharmacological agents to enhance therapeutic outcomes.

Latest Patents

Artur Bauhofer holds a patent for a novel combination of R,R-glycopyrrolate, rolipram, and budesonide. This combination is designed for the treatment of inflammatory diseases, especially respiratory conditions such as bronchial asthma and chronic obstructive pulmonary disease (COPD). The patent outlines a process for producing these combinations and their use in treating rheumatic or autoimmune diseases. The specific formulation aims to achieve a synergistic therapeutic effect through carefully calculated dosage amounts.

Career Highlights

Bauhofer is associated with Meda Pharma GmbH & Co. KG, where he has been instrumental in advancing research and development in pharmaceutical formulations. His work has focused on creating effective treatments that address complex inflammatory conditions.

Collaborations

Artur Bauhofer has collaborated with notable colleagues, including Joachim Maus and Horst Kastrup. These partnerships have contributed to the successful development of innovative therapeutic solutions.

Conclusion

Artur Bauhofer's contributions to the field of medicine through his patent and collaborative efforts highlight his commitment to improving treatment options for patients with inflammatory diseases. His work continues to pave the way for advancements in pharmaceutical science.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…